CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Discontinued Operation, Tax Effect of Discontinued Operation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Discontinued Operation, Tax Effect of Discontinued Operation of -$986.00 thousand for the 12-month period ending 2014-12-27, per its 10-K filed 2015-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2015-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2014-12-27 was -$234.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2014-09-27 was -$90.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2013-12-28 was -$59.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2013-09-28 was -$59.00K, a 125.54% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2014 was -$986.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2013 was -$770.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. discontinued operation, tax effect of discontinued operation for fiscal 2012 was -$2.73M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month |
|---|---|---|---|---|
| 2014-12-27 | -$234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$324.00K derived: sum of 2 quarters · filed 2015-02-17 | -$986.00K 10-K · filed 2015-02-17 | |
| 2014-09-27 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$752.00K 10-Q · filed 2014-10-30 | ||
| 2014-06-28 | -$662.00K 10-Q · filed 2014-08-07 | |||
| 2013-12-28 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$118.00K derived: sum of 2 quarters · filed 2015-02-17 | -$705.00K derived: sum of 3 quarters · filed 2015-02-17 | -$770.00K 10-K · filed 2015-02-17 |
| 2013-09-28 | -$59.00K 10-Q · filed 2013-10-30 | -$646.00K derived: sum of 2 quarters · filed 2013-10-30 | -$711.00K 10-Q · filed 2014-10-30 | -$3.73M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | -$587.00K 10-Q · filed 2013-07-31 | -$652.00K 10-Q · filed 2014-08-07 | -$3.67M derived: sum of 3 quarters · filed 2015-02-17 | -$3.44M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | -$65.00K 10-Q · filed 2013-05-08 | -$3.08M derived: sum of 2 quarters · filed 2015-02-17 | -$2.85M derived: sum of 3 quarters · filed 2015-02-17 | -$2.83M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$2.79M derived: sum of 2 quarters · filed 2015-02-17 | -$2.76M derived: sum of 3 quarters · filed 2015-02-17 | -$2.73M 10-K · filed 2015-02-17 |
| 2012-09-29 | $231.00K 10-Q · filed 2013-10-30 | $258.00K derived: sum of 2 quarters · filed 2013-10-30 | $284.00K 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $27.00K 10-Q · filed 2013-07-31 | $53.00K 10-Q · filed 2013-07-31 | ||
| 2012-03-31 | $27.00K 10-Q · filed 2013-05-08 | |||
| 2011-06-25 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2012-08-07 | -$11.11M 10-Q · filed 2012-08-07 | ||
| 2011-03-26 | -$11.11M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |